163 related articles for article (PubMed ID: 35076435)
1. Treating hypertension in Black patients.
Gardner NJ
JAAPA; 2022 Feb; 35(2):15-18. PubMed ID: 35076435
[TBL] [Abstract][Full Text] [Related]
2. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
[TBL] [Abstract][Full Text] [Related]
3. A Review of ACE Inhibitors and ARBs in Black Patients With Hypertension.
Helmer A; Slater N; Smithgall S
Ann Pharmacother; 2018 Nov; 52(11):1143-1151. PubMed ID: 29808707
[TBL] [Abstract][Full Text] [Related]
4. Changing patterns of initial drug therapy for the treatment of hypertension in a Medicaid population, 1997-2000.
Weiss R; Buckley K; Clifford T
Clin Ther; 2002 Sep; 24(9):1451-62. PubMed ID: 12380636
[TBL] [Abstract][Full Text] [Related]
5. Medicaid prescriber compliance with Joint National Committee VI Hypertension Treatment Guidelines.
Clause SL; Hamilton RA
Ann Pharmacother; 2002 Oct; 36(10):1505-11. PubMed ID: 12243597
[TBL] [Abstract][Full Text] [Related]
6. A review of chemical therapies for treating diabetic hypertension.
Sarafidis PA; Alexandrou ME; Ruilope LM
Expert Opin Pharmacother; 2017 Jun; 18(9):909-923. PubMed ID: 28480805
[TBL] [Abstract][Full Text] [Related]
7. 50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment?
Brown A; Captain B
Am J Ther; 2011 Nov; 18(6):e244-54. PubMed ID: 21436766
[TBL] [Abstract][Full Text] [Related]
8. Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD.
Sinha AD; Agarwal R
Clin J Am Soc Nephrol; 2019 May; 14(5):757-764. PubMed ID: 30425103
[TBL] [Abstract][Full Text] [Related]
9. Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment Guidelines.
Egan BM; Yang J; Rakotz MK; Sutherland SE; Jamerson KA; Wright JT; Ferdinand KC; Wozniak GD
Hypertension; 2022 Feb; 79(2):338-348. PubMed ID: 34784722
[TBL] [Abstract][Full Text] [Related]
10. 2014 Guideline for the Management of High Blood Pressure (Eighth Joint National Committee): Take-Home Messages.
Farooq U; Ray SG
Med Clin North Am; 2015 Jul; 99(4):733-8. PubMed ID: 26042879
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.
Vijan S; Hayward RA
Ann Intern Med; 2003 Apr; 138(7):593-602. PubMed ID: 12667032
[TBL] [Abstract][Full Text] [Related]
12. A compendium of antihypertensive therapy.
Ferdinand KC
J Clin Hypertens (Greenwich); 2011 Sep; 13(9):636-8. PubMed ID: 21896141
[No Abstract] [Full Text] [Related]
13. Relative efficacy of, and some adverse reactions to, different antihypertensive regimens.
Moser M
Am J Cardiol; 1989 Jan; 63(4):2B-7B. PubMed ID: 2563187
[TBL] [Abstract][Full Text] [Related]
14. SGLT2 Inhibitors in Resistant Hypertension: A Sweet Solution.
Tran KC; Hiremath S
Am J Hypertens; 2020 Dec; 33(12):1071-1074. PubMed ID: 32975559
[No Abstract] [Full Text] [Related]
15. Clinical challenges in diagnosing and managing adult hypertension.
Handler J
Cleve Clin J Med; 2015 Dec; 82(12 Suppl 2):S36-41. PubMed ID: 26694890
[TBL] [Abstract][Full Text] [Related]
16. Treatment strategies for isolated systolic hypertension in elderly patients.
Angeli F; Verdecchia P; Masnaghetti S; Vaudo G; Reboldi G
Expert Opin Pharmacother; 2020 Oct; 21(14):1713-1723. PubMed ID: 32584617
[TBL] [Abstract][Full Text] [Related]
17. JNC VI guidelines.
Opie LH
Lancet; 1998 Jan; 351(9098):289; author reply 289-90. PubMed ID: 9457119
[No Abstract] [Full Text] [Related]
18. Comparison of Pharmacy Refill Data With Chemical Adherence Testing in Assessing Medication Nonadherence in a Safety Net Hospital Setting.
Osula D; Wu B; Schesing K; Das SR; Moss E; Alvarez K; Clark C; Halm EA; Brown NJ; Vongpatanasin W
J Am Heart Assoc; 2022 Oct; 11(19):e027099. PubMed ID: 36193931
[TBL] [Abstract][Full Text] [Related]
19. Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.
Volpe M; Tocci G
Vasc Health Risk Manag; 2012; 8():371-80. PubMed ID: 22745561
[TBL] [Abstract][Full Text] [Related]
20. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study.
Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L
BMJ Open; 2022 Jun; 12(6):e057510. PubMed ID: 35688595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
